Posted On: 12/27/2015 3:16:01 PM
Post# of 72444
Re: scottsmith #16956
Who was talking about k?
Imbruvica did $550mm in sales in 2014. Bought for $21BILLION 3 months later by Abbvie which would only get $275mm of sales because Janssen gets 1/2 of ALL sales. That 21BILLION paid for Pharmacyclic is like 70x 2014 sales!!!
Pharmacyclics was already a $10BILLION company after doing the START of phase3 deal with Janssen.
B has way more $$$$ potential than Imbruvica....WAY MORE!
Not a better play in BIO!
Imbruvica did $550mm in sales in 2014. Bought for $21BILLION 3 months later by Abbvie which would only get $275mm of sales because Janssen gets 1/2 of ALL sales. That 21BILLION paid for Pharmacyclic is like 70x 2014 sales!!!
Pharmacyclics was already a $10BILLION company after doing the START of phase3 deal with Janssen.
B has way more $$$$ potential than Imbruvica....WAY MORE!
Not a better play in BIO!
(0)
(0)Scroll down for more posts ▼
